Search and analyze individual stocks with comprehensive metrics

Kashyap Tele Medicines Ltd

KASHYAPIT Enabled Services
7.21+0.00 (+0.00%)
As on 13 Jan 2026, 09:48 amMarket Open

Fundamental Score

...

Kashyap Tele Medicines Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

0.00%
Poor

Return on Capital Employed

0.00%
Poor

Operating Profit Margin (5Y)

-13.40%
Poor

Dividend Yield

0.00%

Valuation Metrics

Price to Earnings

N/A

Market Capitalization

45.19 (Cr)

Industry P/E

33.81x

Growth Metrics

YoY Quarterly Profit Growth

N/A
Poor

YoY Quarterly Sales Growth

-100.00%
Poor

Sales Growth (5Y)

-1.02%

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Excellent

Debt to Equity

0.00x

Interest Coverage

N/A
Poor

Free Cash Flow (5Y)

-0.10 (Cr)

Ownership Structure

Good

Promoter Holding

61.93%
Poor

FII Holding

0.00%
Poor

DII Holding

0.06%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
61.93%
Promoter Holding
45.19 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of KASHYAP across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Balanced Promoter Holding (61.93%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

10 factors identified

Below-Average Return on Equity (0.00%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (0.00%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Margin Pressure Concerns (-13.40%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.

Revenue Contraction (-100.00%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.

Limited Growth History (-1.02% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Negative Free Cash Flow (₹-0.10 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 0.06%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Loading Peer Comparison

Finding companies in the IT Enabled Services sector...

Financial Statements

Comprehensive financial data for Kashyap Tele Medicines Ltd

About KASHYAP

Business Overview

Kashyap Tele-Medicines Limited provides information technology services in India. The company offers software development, onshore and offshore, distribution, implementation, application, trading, buying, selling, import, export, data processing, and internet services. It also establishes, maintains, hires, leases, and runs training centers, training schools, and campuses to provide computer training and education of computer hardware and software application, implementation, and development; runs a cyber cafe; and manages, transmits, and distributes data through own or leased telephone lines and cables. In addition, the company is involved in the software sales business; website development and designing; e-commerce solutions; and information collection, strotation, processing, and transmission services. The company was formerly known as Jindal Online.Com Limited and changed its name to Kashyap Tele-Medicines Limited in August 2005. Kashyap Tele-Medicines Limited was incorporated in 1995 and is based in Navi Mumbai, India. Kashyap Tele-Medicines Limited operates as a subsidiary of June Enterprises Private Limited.

Company Details

Symbol:KASHYAP
Industry:IT Enabled Services
Sector:IT Enabled Services

Key Leadership

Mr. Kalpesh Bipin Sheth
MD & Executive Director
Mr. Anirudh Shah
Chief Financial Officer
Ms. Varsha Sawant
Company Secretary & Compliance Officer

KASHYAP Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)0.00%
Return on Capital Employed0.00%
Operating Profit Margin (5Y)-13.40%
Debt to Equity Ratio0.00
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)-1.02%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit GrowthN/A%
YoY Quarterly Sales Growth-100.00%

Frequently Asked Questions

What is the current price of Kashyap Tele Medicines Ltd (KASHYAP)?

As of 13 Jan 2026, 09:48 am IST, Kashyap Tele Medicines Ltd (KASHYAP) is currently trading at ₹7.21. The stock has a market capitalization of ₹45.19 (Cr).

Is KASHYAP share price Overvalued or Undervalued?

KASHYAP is currently trading at a P/E ratio of 0.00x, compared to the industry average of 33.81x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.

What factors affect the Kashyap Tele Medicines Ltd share price?

Key factors influencing KASHYAP's price include its quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Kashyap Tele Medicines Ltd a good stock for long-term investment?

Kashyap Tele Medicines Ltd shows a 5-year Profit Growth of N/A% and an ROE of 0.00%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Kashyap Tele Medicines Ltd compare with its industry peers?

Kashyap Tele Medicines Ltd competes with major peers in the IT Enabled Services. Investors should compare KASHYAP's P/E of 0.00x and ROE of 0.00% against the industry averages to determine its competitive standing.

What is the P/E ratio of KASHYAP and what does it mean?

KASHYAP has a P/E ratio of N/Ax compared to the industry average of 33.81x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.

How is KASHYAP performing according to Bull Run's analysis?

KASHYAP has a Bull Run fundamental score of 8/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does KASHYAP belong to?

KASHYAP operates in the IT Enabled Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Kashyap Tele Medicines Ltd.

What is Return on Equity (ROE) and why is it important for KASHYAP?

KASHYAP has an ROE of 0.00%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Kashyap Tele Medicines Ltd generates profits from shareholders' equity.

How is KASHYAP's debt-to-equity ratio and what does it indicate?

KASHYAP has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is KASHYAP's dividend yield and is it a good dividend stock?

KASHYAP offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has KASHYAP grown over the past 5 years?

KASHYAP has achieved 5-year growth rates of: Sales Growth -1.02%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in KASHYAP and why does it matter?

Promoters hold 61.93% of KASHYAP shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is KASHYAP's market capitalization category?

KASHYAP has a market capitalization of ₹45 crores, placing it in the Small-cap category.

How volatile is KASHYAP stock?

KASHYAP has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for KASHYAP?

KASHYAP has a 52-week high of ₹N/A and low of ₹N/A.

What is KASHYAP's operating profit margin trend?

KASHYAP has a 5-year average Operating Profit Margin (OPM) of -13.40%, indicating the company's operational efficiency.

How is KASHYAP's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of -100.00% and YoY Profit Growth of N/A%.

What is the institutional holding pattern in KASHYAP?

KASHYAP has FII holding of 0.00% and DII holding of 0.06%. Significant institutional holding often suggests professional confidence in the stock.